• Trending
  • Latest
    Sign in Sign up
    • Log In
    • Register
    • Home
    • Discover
    • Experts
    • Home
    • Discover
    • Experts
    • Learning Lab
    • Home
    • Discover
    • Experts
    • Learning Lab
    • Mashup Score: 1
      Differences in surgical resection rate and risk of malignancy in thyroid cytopathology practice between Western and Asian countries: A systematic review and meta‐analysis - 5 hour(s) ago

      There are certain differences in thyroid cytopathology practice between Western and Asian countries, which affect the major outputs of TBSRTC.

      Source: acsjournals.onlinelibrary.wiley.com
      Categories: General Medicine News
      Tweet Tweets with this article
      • Profile photo of 	CancerCytopath
        CancerCytopath

        There are certain differences in thyroid cytopathology practice between Western and Asian countries, which affect the major outputs of the #BethesdaSystem for Reporting Thyroid Cytopathology. Revisit this 2019 top-cited review: https://t.co/rcQ6QOEl76 #CytoPath #ENTPath https://t.co/bvo39Cb3Tl

    • Mashup Score: 10
      An integrated multi‐omics biomarker approach using molecular profiling and microRNAs for evaluation of pancreatic cyst fluid - 4 day(s) ago

      Although molecular profiling has emerged as an ancillary test for pancreatic cyst fluid (PCF), additional high-sensitivity and -specificity biomarkers are still needed for improved classification. Th…

      Source: acsjournals.onlinelibrary.wiley.com
      Categories: General Medicine News
      Tweet Tweets with this article
      • Profile photo of 	CancerCytopath
        CancerCytopath

        New this week! 📌 An integrated multi-omics biomarker approach using molecular profiling and microRNAs for evaluation of pancreatic cyst fluid https://t.co/KA4moOGjwm #CytoPath @Sinchita_Roy @Aiims1742 @Tony_Y_Hu https://t.co/pgFCiLqMkP

    • Mashup Score: 25
      Cytomorphology and clinicopathologic correlation of TFE3‐rearranged renal cell carcinoma - 5 day(s) ago

      TFE3-rearranged renal cell carcinoma (TFE3-rRCC) harbors gene fusions involving TFE3 with one of many different partner genes. Due to their diverse morphologies, the differential diagnosis is broad a…

      Source: acsjournals.onlinelibrary.wiley.com
      Categories: General Medicine News
      Tweet Tweets with this article
      • Profile photo of 	CancerCytopath
        CancerCytopath

        New & available #OpenAccess! Cytomorphology and clinicopathologic correlation of TFE3-rearranged renal cell carcinoma Read the latest from Tieying Hou MD, PhD (@IUMedSchool) and Xiaoqi Lin MD, PhD (@NU_Pathology): https://t.co/jomsBVT3q9 #CytoPath https://t.co/MRxJewENqW

    • Mashup Score: 21
      Selection of neuroendocrine markers in diagnostic workup of neuroendocrine neoplasms: The real‐world data and machine learning model algorithms - 6 day(s) ago

      Appropriate selection of immunomarkers is important in the diagnostic workup of neuroendocrine neoplasms. The current study suggests that combination of synaptophysin, INSM1, and CD56 results in the …

      Source: acsjournals.onlinelibrary.wiley.com
      Categories: General Medicine News
      Tweet Tweets with this article
      • Profile photo of 	CancerCytopath
        CancerCytopath

        New this week! | Selection of neuroendocrine markers in diagnostic workup of neuroendocrine neoplasms: The real-world data and machine learning model algorithms https://t.co/pWuKagJwIv #CytoPath @gcai1978 @yalepathology https://t.co/daqlP2YbE4

    • Mashup Score: 23
      Low‐risk oncocytic renal neoplasm: A useful cytologic diagnosis - 10 day(s) ago

      The proposed diagnostic category of “low-risk oncocytic renal neoplasm” consists of both oncocytomas and a subset of chromophobe renal cell carcinomas but has a 5-year survival of at least 95%–100%.

      Source: acsjournals.onlinelibrary.wiley.com
      Categories: General Medicine News
      Tweet Tweets with this article
      • Profile photo of 	CancerCytopath
        CancerCytopath

        💥Commentary: Low-risk oncocytic renal neoplasm: A useful cytologic diagnosis https://t.co/HN0bXwO0g1 #CytoPath @eva_wojcik @MerceJorda1 @marthabpitman @MGHPathology https://t.co/CuKSxOGwMM

    • Mashup Score: 4
      The hidden costs of clinical trials - 12 day(s) ago

      Click on the article title to read more.

      Source: acsjournals.onlinelibrary.wiley.com
      Categories: General Medicine News
      Tweet Tweets with this article
      • Profile photo of 	CancerCytopath
        CancerCytopath

        New #CytoSource | The hidden costs of clinical trials: Fierce debate over the reimbursement of indirect costs linked to NIH grants shines a new light on the burden borne by the facilities and participants needed to conduct clinical trials https://t.co/XeHJDwPIGC @bfaquin https://t.co/a44jGf6BGf

    • Mashup Score: 4
      “Other” high‐risk HPV: Challenges in anal cancer screening - 14 day(s) ago

      Click on the article title to read more.

      Source: acsjournals.onlinelibrary.wiley.com
      Categories: General Medicine News
      Tweet Tweets with this article
      • Profile photo of 	CancerCytopath
        CancerCytopath

        New editorial💡| “Other” high-risk HPV: Challenges in anal cancer screening. Future anal cancer studies must evaluate a patient population that is fully representative of those most at risk for anal dysplasia and carcinoma. Learn more: https://t.co/F4YUJOCCzU #CytoPath https://t.co/wl3M3qtFST

    • Mashup Score: 10
      An integrated multi‐omics biomarker approach using molecular profiling and microRNAs for evaluation of pancreatic cyst fluid - 17 day(s) ago

      Although molecular profiling has emerged as an ancillary test for pancreatic cyst fluid (PCF), additional high-sensitivity and -specificity biomarkers are still needed for improved classification. Th…

      Source: acsjournals.onlinelibrary.wiley.com
      Categories: General Medicine News
      Tweet Tweets with this article
      • Profile photo of 	CancerCytopath
        CancerCytopath

        New this week! 📌 An integrated multi-omics biomarker approach using molecular profiling and microRNAs for evaluation of pancreatic cyst fluid https://t.co/KA4moOGjwm #CytoPath @Sinchita_Roy @Aiims1742 @Tony_Y_Hu https://t.co/pgFCiLqMkP

    • Mashup Score: 29
      Intraoperative peritoneal cytology for cervical gastric‐type adenocarcinoma: Cytopathology and clinical impact - 18 day(s) ago

      Positive intraoperative peritoneal washing cytology is more commonly identified in gastric-type adenocarcinoma (GAS) of the cervix compared with the usual type of endocervical adenocarcinoma. In addi…

      Source: acsjournals.onlinelibrary.wiley.com
      Categories: General Medicine News
      Tweet Tweets with this article
      • Profile photo of 	CancerCytopath
        CancerCytopath

        This new study aims to elucidate the frequency of positive peritoneal washing cytology (PWC) in cervical gastric-type adenocarcinoma (GAS), the cytologic characteristics of GAS in PWC, & the prognostic impact of positive PWC findings. https://t.co/rzTy3W2VX6 #CytoPath #GYNPath https://t.co/Bnz2apSyOU

    • Mashup Score: 52
      The diagnostic challenges of medullary thyroid carcinoma: A practical guide for cytopathologists - 19 day(s) ago

      The low incidence of medullary thyroid cancer and its variable cytomorphology can pose significant diagnostic challenges for cytopathologists. In this review, the authors provide practical guidance o…

      Source: acsjournals.onlinelibrary.wiley.com
      Categories: General Medicine News
      Tweet Tweets with this article
      • Profile photo of 	CancerCytopath
        CancerCytopath

        🔓 New #OpenAccess review by Marc P. Pusztaszeri MD & @ZMaleki_cyto offers practical guidance on diagnosing medullary thyroid carcinoma, covering cytologic features, ancillary studies, mimics, and pitfalls. 🔬 https://t.co/J0ocgbmsJZ #CytoPath https://t.co/rGXgxSb8zQ

    Load More

    Cancer Cytopathology

    @CancerCytopath

    Official page of Cancer Cytopathology, a journal of the American Cancer Society. Editor-in-Chief: William C. Faquin, MD, PhD (@bfaquin)

    ASCO 2025

    Advertisement

    Advertisement

    MashupMD
    © 2025 - Mashup Media LLC
    • Terms of Use
    • Privacy Policy
    • Cookie Settings